The company noted that new dose of Risperdal Consta, which is expected to be available by May 1, will be additional options for physicians to individualize ...
The FDA has approved Janssen’s Risperdal Consta (risperidone) 12.5 mg long-acting injection for the treatment of schizophrenia within specific patient ...
The new dose of RISPERDAL® CONSTA® will provide physicians with more options to individualize treatment approaches and adjust therapies when clinical ...